Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
In this 12-month multi-center prospective, site-randomized, two-arm trial, approximately 318 biologic-naïve subjects with RA who are candidates for treatment intensification due to inadequate response to MTX monotherapy will be enrolled at up to 60 study sites.
Epistemonikos ID: 423dd631fc9d4d8c91d09776c503c69e4f3a829c
First added on: Mar 23, 2022